Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2024

Mar 20, 2024

34999_dirs_2024-03-19_a61a5d0e-b35e-4ddf-b1d1-f2a76b285f92.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2024-01-01

Reporting Person: Latkin Jed (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-01-01 Option (right to buy) $6.00 A 500000 Acquired 2031-01-01 Common Stock (500000) Direct

Footnotes

F1: The option vests over a three year period, with 25% vesting on the date of grant and 25% vesting on each anniversary thereafter, subject to the Reporting Person's continued service through each vesting date